An interview with Dr. Tess Lawrie. We discuss the ongoing saga surrounding her meta-analysis on Ivermectin studies for the safety and efficacy against Covid-19. We also touch on the FDA recent announcement cautioning against the use of the drug, and Dr. Andrew Hill.
Dr. Lawrie is the director of E-BMC Ltd. and is committed to improving the quality of healthcare through rigorous research. She is a frequent member of technical teams responsible for developing international guidelines. Her peer-reviewed publications have received in excess of 3000 citations and her ResearchGate score is among the top 5% pf ResearchGate members.
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).